Literature DB >> 7626011

Differential regulation of von Willebrand factor exocytosis and prostacyclin synthesis in electropermeabilized endothelial cell monolayers.

J A Frearson1, P Harrison, M C Scrutton, J D Pearson.   

Abstract

We have developed a system to permeabilize human umbilical vein endothelial cells in monolayer culture by application of a high-voltage electric field. The permeabilized preparation allows access of small molecules (M(r) < 1000) without loss of large cytosolic proteins. Electropermeabilized cells exocytose highly multimeric von Willebrand factor from secretory granules in response to added Ca2+ (EC50 = 0.8 +/- 0.02 microM), with levels comparable with those observed on stimulation of intact endothelial cells by physiological agonists. MgATP2- potentiates Ca(2+)-driven von Willebrand factor secretion. Other nucleoside triphosphates, but not non-hydrolysable analogues, can replace ATP. Electropermeabilized cells also synthesize and release prostacyclin in response to added Ca2+ (EC50 = 0.3 +/- 0.08 microM), but nucleoside triphosphates markedly inhibit, whereas nonhydrolysable GTP analogues increase, Ca(2+)-driven prostacyclin synthesis. We conclude that elevation of the intracellular [Ca2+] is sufficient to cause efficient exocytosis of von Willebrand factor from permeabilized cells, despite evidence that additional second messengers are needed in intact cells. We find no evidence in endothelial cells for a guanine nucleotide-binding protein promoting exocytosis, although one is clearly involved in stimulating Ca(2+)-driven prostacyclin synthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626011      PMCID: PMC1135756          DOI: 10.1042/bj3090473

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  Recommended methods for the determination of four enzymes in blood.

Authors: 
Journal:  Scand J Clin Lab Invest       Date:  1974-06       Impact factor: 1.713

2.  Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells.

Authors:  A Fabiato; F Fabiato
Journal:  J Physiol (Paris)       Date:  1979

3.  Purification and characterization of smooth muscle myosin light chain kinase.

Authors:  R S Adelstein; C B Klee
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

4.  Calcium-dependence of catecholamine release from bovine adrenal medullary cells after exposure to intense electric fields.

Authors:  D E Knight; P F Baker
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

5.  Direct evidence for a role for Ca2+ in amine storage granule secretion by human platelets.

Authors:  D E Knight; M C Scrutton
Journal:  Thromb Res       Date:  1980-11-15       Impact factor: 3.944

6.  Calcium-activated, phospholipid-dependent protein kinase from rat brain. Subcellular distribution, purification, and properties.

Authors:  U Kikkawa; Y Takai; R Minakuchi; S Inohara; Y Nishizuka
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

7.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Effects of isolation and culture on prostaglandin synthesis by porcine aortic endothelial and smooth muscle cells.

Authors:  A Ager; J L Gordon; S Moncada; J D Pearson; J A Salmon; M A Trevethick
Journal:  J Cell Physiol       Date:  1982-01       Impact factor: 6.384

10.  Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture.

Authors:  J D Levine; J M Harlan; L A Harker; M L Joseph; R B Counts
Journal:  Blood       Date:  1982-08       Impact factor: 22.113

View more
  7 in total

1.  Differential exocytosis from human endothelial cells evoked by high intracellular Ca(2+) concentration.

Authors:  G Zupancic; D Ogden; C J Magnus; C Wheeler-Jones; T D Carter
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

2.  Kinetics of Ca2+ release by InsP3 in pig single aortic endothelial cells: evidence for an inhibitory role of cytosolic Ca2+ in regulating hormonally evoked Ca2+ spikes.

Authors:  T D Carter; D Ogden
Journal:  J Physiol       Date:  1997-10-01       Impact factor: 5.182

3.  Membrane capacitance changes induced by thrombin and calcium in single endothelial cells cultured from human umbilical vein.

Authors:  T D Carter; G Zupancic; S M Smith; C Wheeler-Jones; D Ogden
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

4.  Protein tyrosine kinases regulate agonist-stimulated prostacyclin release but not von Willebrand factor secretion from human umbilical vein endothelial cells.

Authors:  C P Wheeler-Jones; M J May; A J Morgan; J D Pearson
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

5.  Synaptotagmin 5 regulates Ca2+-dependent Weibel-Palade body exocytosis in human endothelial cells.

Authors:  Camille Lenzi; Jennifer Stevens; Daniel Osborn; Matthew J Hannah; Ruben Bierings; Tom Carter
Journal:  J Cell Sci       Date:  2019-02-15       Impact factor: 5.285

6.  Temperature-dependence of Weibel-Palade body exocytosis and cell surface dispersal of von Willebrand factor and its propolypeptide.

Authors:  Lindsay Hewlett; Gregor Zupančič; Gregory Mashanov; Laura Knipe; David Ogden; Matthew J Hannah; Tom Carter
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

7.  Cell-cell interaction underlies formation of fluid in the male reproductive tract of the rat.

Authors:  King-Ho Cheung; George P H Leung; Matthew C T Leung; Winnie W C Shum; Wen-Liang Zhou; Patrick Y D Wong
Journal:  J Gen Physiol       Date:  2005-05       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.